0001654954-19-005559.txt : 20190509 0001654954-19-005559.hdr.sgml : 20190509 20190509160727 ACCESSION NUMBER: 0001654954-19-005559 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUNTON ALAN W CENTRAL INDEX KEY: 0001304773 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 19810553 MAIL ADDRESS: STREET 1: VICURON PHARMACEUTICALS INC STREET 2: 455 S GULPH ROAD SUITE 305 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4/A 1 section16.xml PRIMARY DOCUMENT X0306 4/A 2019-03-01 2019-03-04 0001410098 CorMedix Inc. CRMD 0001304773 DUNTON ALAN W C/O CORMEDIX INC. 400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS NJ 07922 true false false Stock Option (Right to Buy Common Stock) 8.50 2019-03-01 4 A false 20000 0 A 2029-03-01 Common Stock 20000 20000 D The vesting of the options was incorrectly reported in the original filing. These options were granted on 3/1/2019. The options vest one-third on the date of grant, one-third on the first anniversary of the date of grant and one-third on the second anniversary of the date of grant. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Alexander M. Donaldson, by power of attorney 2019-05-09